Novellia raises $18M Series A for pharma real-world data

What's the deal? Novellia, a real-world data company focused on the pharmaceutical industry, has raised $18 million in Series A funding led by Spark Capital, CEO Shashi ShankarDealroom has a profile for this one. Try Dealroom → told Axios Pro.

The signal: The round suggests investors still see room for newcomers in the real-world data space, even as it remains crowded with established players. Pharma companies increasingly rely on real-world evidence to support drug development and commercialisation, keeping investor appetite strong despite a competitive landscape.

Read more: Axios